OIG Audit Of FDA Trial Oversight Improvement Efforts Slated For FY 2004
This article was originally published in The Tan Sheet
Executive Summary
HHS' Office of the Inspector General has agreed to conduct a review of FDA efforts to improve its clinical trials program during the government's 2004 fiscal year